Daniel J. Becker's Net Worth
$196 Million
Who is Daniel J. Becker?
Daniel J. Becker has an estimated net worth of $196 Million. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals, Inc., Pandion Therapeutics, Inc., Principia Biopharma Inc., and ACELYRIN, Inc..
SEC CIK
Daniel J. Becker's CIK is 0001752139
Past Insider Trading and Trends
2020 was Daniel J. Becker's most active year for acquiring shares with 9 total transactions. Daniel J. Becker's most active month to acquire stocks was the month of August. 2018 was Daniel J. Becker's most active year for disposing of shares, totalling 5 transactions. Daniel J. Becker's most active month to dispose stocks was the month of August. 2019 saw Daniel J. Becker paying a total of $19,224,725.97 for 677,840 shares, this is the most they've acquired in one year. In 2021 Daniel J. Becker cashed out on 2,842,880 shares for a total of $169,732,980.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $15.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
∞
| 5K |
$16.00 | $80,000.00 | 5K |
May 26 - Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pandion Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.83M |
$60.00 | -$169,732,980.00 |
0
|
Apr 1
| |||
Form 4
| +7.52% | 197.72K |
$15.12 | $2,989,465.92 | 2.83M |
Nov 19
| |||
Form 4
| +1.13% | 29.39K |
$15.29 | $449,399.93 | 2.63M |
Nov 17 - Nov 18
| |||
Form 4
|
∞
| 2.6M |
$18.00 | $18,000.00 | 2.6M |
Jul 17 - Jul 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Principia Biopharma Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -667.60K |
$100.00 | -$66,760,000.00 |
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
| +8.98% | 55K |
$29.94 | $1,646,700.00 | 667.6K |
Nov 20
| |||
Form 4
| +14.50% | 77.6K |
$33.48 | $2,598,025.97 | 612.6K |
Oct 28 - Oct 29
| |||
Form 4
|
∞
| 535K |
$28.00 | $14,980,000.00 | 535K |
Oct 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 4
|
∞
| 2.63M |
$17.00 |
—
| 2.63M |
Sep 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACELYRIN, Inc. (SLRN) Snapshot price: $7.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.03% | -1.00 |
$6.86 | -$6.86 | 3K |
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 3K |
$18.00 | $54,000.00 | 3K |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||